Description: Recent advancements in oncology transform the way cancer is detected, understood, and treated. Innovations such as molecular imaging, genomic sequencing, and biomarker-based tests enable precise diagnoses, improving the chances of successful intervention. Breakthroughs in targeted therapies, immunotherapy, and personalized medicine shift cancer treatment toward more tailored, effective strategies. Together, these developments improve patient outcomes and quality of life while redefining the future of oncology by integrating technology, biology, and clinical care. Advancements in Cancer Diagnostics and Therapeutics explores emerging trends and innovative techniques in cancer therapeutics and future perspectives that shape the field. It examines cutting-edge approaches in cancer diagnosis, prognosis, therapeutics, and treatment. This book covers topics such as gene editing, molecular diagnostics, and pharmacology, and is a useful resource for engineers, oncologists, medical and healthcare professionals, academicians, researchers, and scientists.
Brief description: Ajit Prakash, an accomplished researcher, earned his B.Sc. in Biotechnology from Jamia Millia Islamia and M.Sc. in Genomics from Madurai Kamaraj University, India. He obtained his Ph.D. in Biochemistry from Nanyang Technological University, Singapore. Following a postdoctoral fellowship at the University of Cambridge, UK, and a stint as an assistant professor at Lovely Professional University, he pursued a second postdoc at the University of North Carolina, Chapel Hill, where he currently works as a Research Associate. In his over five years of postdoctoral research, Dr. Ajit has made significant contributions to protein biochemistry and molecular biology, particularly in the field of cancer research. His impact is evident in publishing 17+ high-impact research papers/book chapters. Beyond his research, Dr. Ajit Prakash holds editorial positions in various prestigious journals and also serves as an expert reviewer. He is an esteemed member of the "American Heart Association" and the 'International Natural Product Sciences Taskforce', USA. His journey is a testament to his unwavering commitment to advancing scientific understanding and progress.